Stock Market Today: Stocks' Momentum Stalls After Shocking Snap Earnings
The Snapchat parent posted its slowest quarterly revenue growth on record and said it plans to cut back on hiring.
The Nasdaq's impressive multi-day winning streak came to a screeching halt on Friday as a negative earnings reaction for social media stock Snap (SNAP, -39.1%) weighed on the broader tech sector.
The parent company of photo-sharing app Snapchat last night reported its weakest quarter ever for revenue growth (+13% year-over-year to $1.11 billion). SNAP also swung to a per-share loss of 2 cents from earnings of 10 cents per share in Q2 2021, while daily active users were up 18% to 347 million. All three metrics fell short of what Wall Street was expecting. Additionally, the company said it will "substantially" slow hiring in order to cut costs.
Twitter (TWTR, +1.1%) earnings were also in focus today. Ahead of today's open, the social media platform said second-quarter revenue fell 0.8% year-over-year to $1.18 billion – coming up well short of analysts' estimates – with advertising revenue rising just 2% for the three-month period.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The company's revenue was "hurt by a tougher ad landscape, as well as negative implications related to the pending Elon Musk acquisition," says CFRA Research analyst Angelo Zino. "While it is impossible to decipher the exact impact Musk's actions have had on TWTR, we think results do provide additional support that Elon has had a notable detrimental impact on the company's fundamentals." As for "Musk's actions," the analyst is referring to the Tesla (TSLA, -0.2%) CEO terminating his $44 billion buyout of Twitter, which is resulting in a court battle between the two parties.
After three straight sessions of solid gains, the tech-heavy Nasdaq Composite slumped 1.9% to end at 11,843. The S&P 500 Index (-0.9% at 3,961) and Dow Jones Industrial Average (-0.4% at 31,899) also snapped their three-day win streaks.
Despite today's negative price action, all three major benchmarks ended higher on a weekly basis.
Other news in the stock market today:
- The small-cap Russell 2000 shed 1.6% to 1,806.
- U.S. crude futures slumped 1.7% to end at $94.70 per barrel.
- Gold futures rose 0.8% to end at $1,727.40 an ounce.
- Bitcoin retreated 2.6% to $22,588.60. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m.)
- Verizon Communications (VZ) was the worst Dow Jones stock today, sinking 6.7% after the telecommunications company reported lower-than-expected second-quarter earnings of $1.31 per share and cut its full-year forecast. Q2 revenue of $33.79 billion came in just above the consensus. " We believe VZ is currently between a rock and a hard place," says CFRA Research analyst Keith Snyder (Sell). "On the one side you have AT&T (T), who is being extremely aggressive with promotions, and on the other, you have T-Mobile (TMUS), who has a vastly superior 5G network currently.
- American Express (AXP) gained 2.0% after the credit card company reported earnings. In its second quarter, AXP brought in earnings of $2.57 per share on $13.4 billion in revenue, more than analysts were expecting. The company also boosted its full-year revenue forecast. "We are maintaining our Buy rating on American Express following Q2 earnings, which were helped by a continued strong rebound in billed business, but hurt by a $1 billion swing in credit costs with a $410 million loss provision versus a $606 million credit loss recapture," says Argus Research analyst Stephen Biggar.
Next Week Will Be a Busy (and Potentially Volatile) One
There's plenty on tap next week that could spark further volatility in markets. For starters, we're entering the busiest week of the second-quarter earnings season so far, with several mega-cap tech names – such as Apple (AAPL) and Microsoft (MSFT) – set to report. Wall Street will be watching to "see how margins are holding up in the previous stock-market darlings, and hoping they paint a prettier picture than the underperformance from U.S. banks," says Sophie Lund-Yates, equity analyst at U.K.-based financial firm Hargreaves Lansdown.
In addition, the Federal Reserve will issue its latest policy decision at 2 p.m. Eastern time on Wednesday, July 27, with a press conference from Fed Chair Jerome Powell to follow.
"The market response will likely be closely tied to comments during the press conference and updated summary of economic projections," says Timothy Chubb, chief investment officer at registered investment adviser Girard, a Univest Wealth Division.
The market is currently pricing in a 75 basis-point (a basis point is one-one hundredth of a percentage point) rate hike, and any deviation from this could spark a reaction, Chubb says. He adds that other significant market moves could "be associated with commentary or language that suggests the current rate of tightening policy is either too much or not enough to break the back of inflation."
Investors looking for sturdier ground amid stormier days can find it in some of the more defensive sectors, such as healthcare and real estate investment trusts (REITs), which tend to be able to withstand roller-coaster markets thanks to stable growth and attractive dividend yields. But for more ideas, check out this list of 43 top stocks for a tumultuous market, compiled by strategists at UBS Research Management. The names featured here are the firm's highest-conviction picks to ride out periods of volatility.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Will President Trump's Medicare Executive Order Raise Drug Prices?
President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare enrollees.
By Donna Fuscaldo Published
-
Stock Market Today: Dow Adds 538 Points on First Trading Day of Second Trump Administration
Stocks rise while the White House issues a historic series of executive orders.
By David Dittman Published
-
Stock Market Today: Dow Adds 538 Points on First Trading Day of Second Trump Administration
Stocks rise while the White House issues a historic series of executive orders.
By David Dittman Published
-
Stock Market Today: Stocks Jump Ahead of Trump Inauguration
The Dow and S&P 500 scored their biggest weekly gains since the early November election.
By Karee Venema Published
-
Stock Market Today: Stocks Pause After a Big Rally
The Nasdaq continues to lag the S&P 500 and the Dow so far in 2025.
By David Dittman Published
-
Stock Market Today: Dow Pops 703 Points on Cooler Inflation
A benign reading from the Consumer Price Index report assuaged market fears about the path of borrowing costs.
By Dan Burrows Published
-
Stock Market Today: Stocks Are Mixed Ahead of CPI
Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.
By David Dittman Published
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
By Karee Venema Published
-
Stock Market Today: Dow Slides 697 Points on Super-Hot Jobs Data
When the December nonfarm payrolls report hit the tape, there was no question which way stocks would go at Friday's opening bell.
By David Dittman Published
-
Stock Market Today: Stocks End Mixed After FOMC Minutes
The minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
By Karee Venema Published